<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37436254</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1806-9460</ISSN><JournalIssue CitedMedium="Internet"><Volume>142</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Sao Paulo medical journal = Revista paulista de medicina</Title><ISOAbbreviation>Sao Paulo Med J</ISOAbbreviation></Journal><ArticleTitle>Noninvasive mechanical ventilation assistance in amyotrophic lateral sclerosis: a systematic review.</ArticleTitle><Pagination><StartPage>e2022470</StartPage><MedlinePgn>e2022470</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2022470</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1590/1516-3180.2022.0470.R1.100423</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1516-31802024000100203</ELocationID><Abstract><AbstractText Label="BACKGROUND">Respiratory failure is the most common cause of death in patients with amyotrophic lateral sclerosis (ALS), and morbidity is related to poor quality of life (QOL). Non-invasive ventilation (NIV) may be associated with prolonged survival and QOL in patients with ALS.</AbstractText><AbstractText Label="OBJECTIVES">To assess whether NIV is effective and safe for patients with ALS in terms of survival and QOL, alerting the health system.</AbstractText><AbstractText Label="DESIGN AND SETTING">Systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting standards using population, intervention, comparison, and outcome strategies.</AbstractText><AbstractText Label="METHODS">The Cochrane Library, CENTRAL, MEDLINE, LILACS, EMBASE, and CRD databases were searched based on the eligibility criteria for all types of studies on NIV use in patients with ALS published up to January 2022. Data were extracted from the included studies, and the findings were presented using a narrative synthesis.</AbstractText><AbstractText Label="RESULTS">Of the 120 papers identified, only 14 were related to systematic reviews. After thorough reading, only one meta-analysis was considered eligible. In the second stage, 248 studies were included; however, only one systematic review was included. The results demonstrated that NIV provided relief from the symptoms of chronic hypoventilation, increased survival, and improved QOL compared to standard care. These results varied according to clinical phenotype.</AbstractText><AbstractText Label="CONCLUSIONS">NIV in patients with ALS improves the outcome and can delay the indication for tracheostomy, reducing expenditure on hospitalization and occupancy of intensive care unit beds.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION">PROSPERO database: CRD42021279910 - https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=279910.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cunha-Correia</LastName><ForeName>Carolina da</ForeName><Initials>CD</Initials><Identifier Source="ORCID">0000-0003-2605-2784</Identifier><AffiliationInfo><Affiliation>PhD. Neurologist and Professor, Department of Neurology, Hospital Universit&#xe1;rio Oswaldo Cruz (HUOC), Universidade de Pernambuco (UPE), Recife (PE), Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gama</LastName><ForeName>Mylana Dandara Pereira</ForeName><Initials>MDP</Initials><Identifier Source="ORCID">0000-0001-6895-5848</Identifier><AffiliationInfo><Affiliation>MD. Resident Physician, Department of Neurology, Hospital Universit&#xe1;rio Oswaldo Cruz (HUOC), Universidade de Pernambuco (UPE), Recife (PE), Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fontana</LastName><ForeName>Pedro Nogueira</ForeName><Initials>PN</Initials><Identifier Source="ORCID">0000-0002-3467-7613</Identifier><AffiliationInfo><Affiliation>MSc. Neurologist, Department of Neurology, Hospital Universit&#xe1;rio Oswaldo Cruz (HUOC), Universidade de Pernambuco (UPE), Recife (PE), Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fantini</LastName><ForeName>Francisca Goreth Malheiro Moraes</ForeName><Initials>FGMM</Initials><Identifier Source="ORCID">0000-0002-9632-6253</Identifier><AffiliationInfo><Affiliation>MD. Neurologist and Neurophysiologist, Santa Casa de Miseric&#xf3;rdia de Fernand&#xf3;polis (SCF), Fernand&#xf3;polis (SP), Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prado</LastName><ForeName>Gilmar Fernandes</ForeName><Initials>GF</Initials><Identifier Source="ORCID">0000-0002-3383-8198</Identifier><AffiliationInfo><Affiliation>PhD. Neurologist and Professor, Department of Medicine, Escola Paulista de Medicina (EPM), Universidade Federal de S&#xe3;o Paulo (UNIFESP), S&#xe3;o Paulo (SP), Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dourado J&#xfa;nior</LastName><ForeName>M&#xe1;rio Em&#xed;lio Teixeira</ForeName><Initials>MET</Initials><Identifier Source="ORCID">0000-0002-9462-2294</Identifier><AffiliationInfo><Affiliation>PhD. Neurologist and Professor, Department of Integrated Medicine, Centro de Ci&#xea;ncias da Sa&#xfa;de (CCS), Universidade Federal do Rio Grande do Norte (UFRN), Natal (RN), Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwingel</LastName><ForeName>Paulo Adriano</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0002-2935-3403</Identifier><AffiliationInfo><Affiliation>PhD. Sports Physiologist and Associate Professor, Human Performance Research Laboratory, Universidade de Pernambuco (UPE), Petrolina (PE), Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Sao Paulo Med J</MedlineTA><NlmUniqueID>100897261</NlmUniqueID><ISSNLinking>1516-3180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063087" MajorTopicYN="Y">Noninvasive Ventilation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>
<b>Conflicts of interest:</b> None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>10</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37436254</ArticleId><ArticleId IdType="pmc">PMC10328442</ArticleId><ArticleId IdType="doi">10.1590/1516-3180.2022.0470.R1.100423</ArticleId><ArticleId IdType="pii">S1516-31802024000100203</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chi&#xf2; A, Logroscino G, Traynor BJ, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41(2):118&#x2013;130. doi: 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha JA, Reis C, Sim&#xf5;es F, Fonseca J, Mendes Ribeiro J. Diagnostic investigation and multidisciplinary management in motor neuron disease. J Neurol. 2005;252(12):1435&#x2013;1447. doi: 10.1007/s00415-005-0007-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-005-0007-9</ArticleId><ArticleId IdType="pubmed">16362828</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechtzin N. Respiratory effects of amyotrophic lateral sclerosis: problems and solutions. Respir Care. 2006;51(8):871&#x2013;881. discussion 881-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">16867198</ArticleId></ArticleIdList></Reference><Reference><Citation>Prado Lde G, Bicalho IC, Vidigal-Lopes M, et al. Amyotrophic lateral sclerosis in Brazil: case series and review of the Brazilian literature. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3-4):282&#x2013;288. doi: 10.3109/21678421.2016.1143011.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1143011</ArticleId><ArticleId IdType="pubmed">26854959</ArticleId></ArticleIdList></Reference><Reference><Citation>Radunovic A, Annane D, Rafiq MK, Brassington R, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2017;10(10):CD004427. doi: 10.1002/14651858.CD004427.pub4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004427.pub4</ArticleId><ArticleId IdType="pmc">PMC6485636</ArticleId><ArticleId IdType="pubmed">28982219</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamankar N, Coan G, Weaver B, Mitchell CS. Associative increases in amyotrophic lateral sclerosis survival duration with non-invasive ventilation initiation and usage protocols. Front Neurol. 2018;9:578&#x2013;578. doi: 10.3389/fneur.2018.00578.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00578</ArticleId><ArticleId IdType="pmc">PMC6052254</ArticleId><ArticleId IdType="pubmed">30050497</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Rosenberg JA, Gelinas DF, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52(7):1311&#x2013;1323. doi: 10.1212/wnl.52.7.1311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.52.7.1311</ArticleId><ArticleId IdType="pubmed">10227612</ArticleId></ArticleIdList></Reference><Reference><Citation>Methley AM, Campbell S, Chew-Graham C, McNally R, Cheraghi-Sohi S. PICO PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res. 2014;14:579&#x2013;579. doi: 10.1186/s12913-014-0579-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-014-0579-0</ArticleId><ArticleId IdType="pmc">PMC4310146</ArticleId><ArticleId IdType="pubmed">25413154</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>da Costa Santos CM, de Mattos Pimenta CA, Nobre MR. The PICO strategy for the research question construction and evidence search. Rev Lat Am Enfermagem. 2007;15(3):508&#x2013;511. doi: 10.1590/s0104-11692007000300023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0104-11692007000300023</ArticleId><ArticleId IdType="pubmed">17653438</ArticleId></ArticleIdList></Reference><Reference><Citation>Howick J, Chalmers I, Glasziou P, et al.   The Oxford 2011 Levels of Evidence. Oxford: Oxford Centre for Evidence-Based Medicine; 2011.  [Accessed in 2023 (March
22)].  Available from:  https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence
.</Citation></Reference><Reference><Citation>Berlowitz DJ, Howard ME, Fiore JF, Jr, et al. Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort. J Neurol Neurosurg Psychiatry. 2016;87(3):280&#x2013;286. doi: 10.1136/jnnp-2014-310055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-310055</ArticleId><ArticleId IdType="pubmed">25857659</ArticleId></ArticleIdList></Reference><Reference><Citation>Gooch CL, Pracht E, Borenstein AR. The burden of neurological disease in the United States: A summary report and call to action. Ann Neurol. 2017;81(4):479&#x2013;484. doi: 10.1002/ana.24897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24897</ArticleId><ArticleId IdType="pubmed">28198092</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>